Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation
Xin Qiu, Dian Hu, Wenqiang Chen, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2018) Vol. 1864, Iss. 5, pp. 1754-1769
Open Access | Times Cited: 134

Showing 1-25 of 134 citing articles:

Controversies around epithelial–mesenchymal plasticity in cancer metastasis
Elizabeth D. Williams, Dingcheng Gao, Andrew Redfern, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 12, pp. 716-732
Open Access | Times Cited: 373
Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion
Yuanyuan Jiang, Hanxiang Zhan
Cancer Letters (2019) Vol. 468, pp. 72-81
Closed Access | Times Cited: 270
Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
Peixin Dong, Ying Xiong, Junming Yue, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 267
Programmed death ligand 1 signals in cancer cells
Anand Kornepati, Ratna K. Vadlamudi, Tyler J. Curiel
Nature reviews. Cancer (2022) Vol. 22, Iss. 3, pp. 174-189
Open Access | Times Cited: 266
Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy
Hongtao Chen, Hao Liu, Minjie Mao, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 259
Emerging role of tumor cell plasticity in modifying therapeutic response
Siyuan Qin, Jingwen Jiang, Yi Lü, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 192
Increased Programmed Death-Ligand 1 is an Early Epithelial Cell Response to Helicobacter pylori Infection
Loryn Holokai, Jayati Chakrabarti, Taylor Broda, et al.
PLoS Pathogens (2019) Vol. 15, Iss. 1, pp. e1007468-e1007468
Open Access | Times Cited: 153
Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8+ T cell exclusion
Wenli Fang, Ting Zhou, He Shi, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 147
ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer
Iris C. Salaroglio, Eleonora Mungo, Elena Gazzano, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 10, pp. 2505-2505
Open Access | Times Cited: 142
KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway
Wenwen Du, Jianjie Zhu, Yuanyuan Zeng, et al.
Cell Death and Differentiation (2020) Vol. 28, Iss. 4, pp. 1284-1300
Open Access | Times Cited: 102
The Prognostic and Therapeutic Value of PD-L1 in Glioma
Ruo Qiao Chen, Feng Liu, Xin Qiu, et al.
Frontiers in Pharmacology (2019) Vol. 9
Open Access | Times Cited: 100
The Hallmarks of Glioblastoma: Heterogeneity, Intercellular Crosstalk and Molecular Signature of Invasiveness and Progression
Filippo Torrisi, Cristiana Alberghina, Simona D’Aprile, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 806-806
Open Access | Times Cited: 65
PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway
Fang Wang, Liqiong Yang, Mintao Xiao, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 43
Key events in cancer: Dysregulation of SREBPs
Yunkuo Li, Shouwang Wu, Xiaodong Zhao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 22
Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle
Marco Cordani, Raffaele Strippoli, Flavia Trionfetti, et al.
Cancer Letters (2024) Vol. 585, pp. 216661-216661
Open Access | Times Cited: 9
The canonical TGF-β/Smad signalling pathway is involved in PD-L1-induced primary resistance to EGFR-TKIs in EGFR-mutant non-small-cell lung cancer
Yang Zhang, Yuanyuan Zeng, Ting Liu, et al.
Respiratory Research (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 74
A Critical Insight into the Clinical Translation of PD-1/PD-L1 Blockade Therapy in Clear Cell Renal Cell Carcinoma
Caroline E. Nunes‐Xavier, J.C. Angulo, Rafael Pulido, et al.
Current Urology Reports (2019) Vol. 20, Iss. 1
Closed Access | Times Cited: 66
LncRNA KCNQ1OT1 sponges miR-15a to promote immune evasion and malignant progression of prostate cancer via up-regulating PD-L1
Qihua Chen, Bo Li, De-Guo Liu, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 63
Dual inhibition of TGFβ signaling and CSF1/CSF1R reprograms tumor-infiltrating macrophages and improves response to chemotherapy via suppressing PD-L1
Tsung-Wei Chen, Wei-Ze Hung, Shu‐Fen Chiang, et al.
Cancer Letters (2022) Vol. 543, pp. 215795-215795
Closed Access | Times Cited: 35
PD-1/PD-L1 axis in organ fibrosis
Youliang Zhao, Yaqian Qu, Changfu Hao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
The α9 Nicotinic Acetylcholine Receptor Mediates Nicotine-Induced PD-L1 Expression and Regulates Melanoma Cell Proliferation and Migration
Hai Duong Nguyen, You-Cheng Liao, Yuan‐Soon Ho, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1991-1991
Open Access | Times Cited: 52
The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome
Andrew Redfern, Lisa Spalding, Erik W. Thompson
Clinical & Experimental Metastasis (2018) Vol. 35, Iss. 4, pp. 285-308
Closed Access | Times Cited: 50
HDAC3 modulates cancer immunity via increasing PD-L1 expression in pancreatic cancer
Guo‐fu Hu, Nan He, Chuanqi Cai, et al.
Pancreatology (2019) Vol. 19, Iss. 2, pp. 383-389
Closed Access | Times Cited: 46
H19/let‑7/Lin28 ceRNA network mediates autophagy inhibiting epithelial‑mesenchymal transition in breast cancer
Hanchu Xiong, Jianguo Shen, Zihan Chen, et al.
International Journal of Oncology (2020)
Open Access | Times Cited: 41
PD-L1 Reverse Signaling in Dermal Dendritic Cells Promotes Dendritic Cell Migration Required for Skin Immunity
Erin D. Lucas, Johnathon Schafer, Jennifer L. Matsuda, et al.
Cell Reports (2020) Vol. 33, Iss. 2, pp. 108258-108258
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top